本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Salarius Pharmaceuticals Inc

1.08
+0.03002.86%
盘后1.04-0.0400-3.70%19:59 EDT
成交量:202.41万
成交额:209.94万
市值:229.75万
市盈率:-0.19
高:1.13
开:1.00
低:0.9900
收:1.05
数据加载中...
2025/06/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/06/16

重要事件披露

Form 8-K - Current report
2025/06/11

重要事件披露

Form 8-K - Current report
2025/05/22

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/25

重要事件披露

Form 8-K - Current report
2025/04/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/28

重要事件披露

Form 8-K - Current report
2025/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/01/21

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/01/17

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/27

SEC问询函

Form CORRESP - Correspondence
2024/12/23

重要事件披露

Form 8-K - Current report
2024/12/16

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/27

重要事件披露

Form 8-K - Current report